{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:05:41Z","timestamp":1776938741151,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41433-023-02428-9","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T13:03:03Z","timestamp":1677243783000},"page":"1009-1013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term outcomes of margin-controlled excision for eyelid melanoma"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-8006","authenticated-orcid":false,"given":"John C.","family":"Bladen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"2428_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cps.2009.08.005","volume":"37","author":"DL Larson","year":"2010","unstructured":"Larson DL, Larson JD. Head and neck melanoma. Clin Plast Surg. 2010;37:73\u201377.","journal-title":"Clin Plast Surg"},{"key":"2428_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/IIO.0b013e3181b7eea7","volume":"49","author":"R Sanchez","year":"2009","unstructured":"Sanchez R, Ivan D, Esmaeli B. Eyelid and periorbital cutaneous malignant melanoma. Int Ophthalmol Clin. 2009;49:25\u201343.","journal-title":"Int Ophthalmol Clin"},{"key":"2428_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.clindermatol.2014.10.010","volume":"33","author":"CL Shields","year":"2015","unstructured":"Shields CL, Kels JG, Shields JA. Melanoma of the eye: revealing hidden secrets, one at a time. Clin Dermatol. 2015;33:183\u201396.","journal-title":"Clin Dermatol"},{"key":"2428_CR4","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-05-2447","volume":"12","author":"G Saldanha","year":"2006","unstructured":"Saldanha G, Potter L, Daforno P, Pringle JH. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res. 2006;12:4499\u2013505.","journal-title":"Clin Cancer Res"},{"key":"2428_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ophtha.2006.08.043","volume":"114","author":"FM Chan","year":"2007","unstructured":"Chan FM, O\u2019Donnell BA, Whitehead K, Ryman W, Sullivan TJ. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology. 2007;114:187\u201392.","journal-title":"Ophthalmology"},{"key":"2428_CR6","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1017\/S0022215116000852","volume":"130","author":"OA Ahmed","year":"2016","unstructured":"Ahmed OA, Kelly C. Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S133\u2013S141.","journal-title":"J Laryngol Otol"},{"key":"2428_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJM198805053181804","volume":"318","author":"U Veronesi","year":"1988","unstructured":"Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318:1159\u201362.","journal-title":"N Engl J Med"},{"key":"2428_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.IOP.0000056141.97930.E8","volume":"19","author":"B Esmaeli","year":"2003","unstructured":"Esmaeli B, Youssef A, Naderi A, Ahmadi MA, Meyer DR, McNab A. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report. Ophthalmic Plast Reconstr Surg. 2003;19:96\u2013101.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2428_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.critrevonc.2015.12.002","volume":"99","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Liu W, Gotlieb V. The rapidly evolving therapies for advanced melanoma\u2013towards immunotherapy, molecular targeted therapy, and beyond. Crit Rev Oncol Hematol. 2016;99:91\u201399.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2428_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/17460441.2016.1201057","volume":"11","author":"A Kim","year":"2016","unstructured":"Kim A, Cohen MS. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma. Expert Opin Drug Discov. 2016;11:907\u201316.","journal-title":"Expert Opin Drug Discov"},{"key":"2428_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ctrv.2015.05.012","volume":"41","author":"O Michielin","year":"2015","unstructured":"Michielin O, Hoeller C. Gaining momentum: new options and opportunities for the treatment of advanced melanoma. Cancer Treat Rev. 2015;41:660\u201370.","journal-title":"Cancer Treat Rev"},{"key":"2428_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3322\/caac.21224","volume":"64","author":"V Saranga-Perry","year":"2014","unstructured":"Saranga-Perry V, Ambe C, Zager JS, Kudchadkar RR. Recent developments in the medical and surgical treatment of melanoma. CA Cancer J Clin. 2014;64:171\u201385.","journal-title":"CA Cancer J Clin"},{"key":"2428_CR13","unstructured":"National Institute for Health and Care Excellence. Melanoma: assessment and management. https:\/\/www.nice.org.uk\/guidance\/ng14."},{"key":"2428_CR14","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/S0161-6420(03)00670-5","volume":"110","author":"R Malhotra","year":"2003","unstructured":"Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology. 2003;110:2011\u20138.","journal-title":"Ophthalmology"},{"key":"2428_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archderm.140.9.1087","volume":"140","author":"SC Huilgol","year":"2004","unstructured":"Huilgol SC, Selva D, Chen C, Hill DC, James CL, Gramp A, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol. 2004;140:1087\u201392.","journal-title":"Arch Dermatol"},{"key":"2428_CR16","first-page":"17","volume":"35","author":"S-Y Then","year":"2009","unstructured":"Then S-Y, Malhotra R, Barlow R, Kurwa H, Huilgol S, Joshi N, et al. Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma. Dermatol Surg. 2009;35:17\u201323.","journal-title":"Dermatol Surg"},{"key":"2428_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472\u201392.","journal-title":"CA Cancer J Clin"},{"key":"2428_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaad.2015.04.014","volume":"73","author":"HW Higgins II","year":"2015","unstructured":"Higgins HW II, Lee KC, Galan A, Leffell DJ. Melanoma in situ: Part I. Epidemiology, screening, and clinical features. J Am Acad Dermatol. 2015;73:181\u201390.","journal-title":"J Am Acad Dermatol"},{"key":"2428_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.jid.2021.12.003","volume":"142","author":"NR Kurtansky","year":"2021","unstructured":"Kurtansky NR, Dusza SW, Halpern AC, Hartman RI, Geller AC, Marghoob AA, et al. An epidemiologic analysis of melanoma overdiagnosis in the United States, 1975-2017. J invest Dermatol. 2021;142:1804\u201311.e6.","journal-title":"J invest Dermatol"},{"key":"2428_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8\u201329.","journal-title":"CA Cancer J Clin"},{"key":"2428_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13671-012-0035-5","volume":"2","author":"ST Chen","year":"2013","unstructured":"Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013;2:24\u201334.","journal-title":"Curr Dermatol Rep"},{"key":"2428_CR22","unstructured":"CRUK. Melanoma skin cancer mortality. 2021."},{"key":"2428_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.bjc.6603216","volume":"95","author":"A Downing","year":"2006","unstructured":"Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95:91\u20135.","journal-title":"Br J Cancer"},{"key":"2428_CR24","doi-asserted-by":"crossref","unstructured":"Go CC, Kim DH, Go BC, McGeehan B, Brice\u00f1o CA. Clinicopathologic characteristics and prognostic factors impacting survival in melanoma of the eyelid. Am J Ophthalmol. 2022;234:71\u201380.","DOI":"10.1016\/j.ajo.2021.07.031"},{"key":"2428_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/bjophthalmol-2014-305140","volume":"98","author":"VT Yin","year":"2014","unstructured":"Yin VT, Warneke CL, Merritt HA, Esmaeli B. Number of excisions required to obtain clear surgical margins and prognostic value of AJCC T category for patients with eyelid melanoma. Br J Ophthalmol. 2014;98:1681\u20135.","journal-title":"Br J Ophthalmol"},{"key":"2428_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/09286586.2020.1767152","volume":"27","author":"S-K Jung","year":"2020","unstructured":"Jung S-K, Lim J, Yang S-W, Jee D, Won Y-J. Nationwide trends in the incidence and survival of eyelid skin cancers in Korea. Ophthalmic Epidemiol. 2020;27:438\u201348.","journal-title":"Ophthalmic Epidemiol"},{"key":"2428_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejca.2019.11.014","volume":"126","author":"C Garbe","year":"2020","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics - Update 2019. Eur J Cancer. 2020;126:141\u201358.","journal-title":"Eur J Cancer"},{"key":"2428_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/BF02305762","volume":"3","author":"CP Karakousis","year":"1996","unstructured":"Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol. 1996;3:446\u201352.","journal-title":"Ann Surg Oncol"},{"key":"2428_CR29","first-page":"101","volume":"8","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 2001;8:101\u20138.","journal-title":"Ann Surg Oncol"},{"key":"2428_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/01.sla.0000152014.89434.96","volume":"241","author":"J Gregory McKinnon","year":"2005","unstructured":"Gregory McKinnon J, Starritt EC, Scolyer RA, McCarthy WH, Thompson JF. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas. Ann Surg. 2005;241:326\u201333.","journal-title":"Ann Surg"},{"key":"2428_CR31","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1200\/JCO.2009.26.2063","volume":"28","author":"E Romano","year":"2010","unstructured":"Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol. 2010;28:3042\u20137.","journal-title":"J Clin Oncol"},{"key":"2428_CR32","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1007\/s12325-021-01783-x","volume":"38","author":"EB Friedman","year":"2021","unstructured":"Friedman EB, Scolyer RA, Williams GJ, Thompson JF. Melanoma in situ: a critical review and re-evaluation of current excision margin recommendations. Adv Ther. 2021;38:3506\u201330.","journal-title":"Adv Ther"},{"key":"2428_CR33","doi-asserted-by":"crossref","unstructured":"Tzellos T, Kyrgidis A, Mocellin S, Chan A-W, Pilati P, Apalla Z. Interventions for melanoma in situ, including lentigo maligna. Cochrane Database Syst Rev. 2014:CD010308.","DOI":"10.1002\/14651858.CD010308.pub2"},{"key":"2428_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13014-020-01615-2","volume":"15","author":"A Hendrickx","year":"2020","unstructured":"Hendrickx A, Cozzio A, Plasswilm L, Panje CM. Radiotherapy for lentigo maligna and lentigo maligna melanoma \u2013 a systematic review. Radiat Oncol. 2020;15:174.","journal-title":"Radiat Oncol"},{"key":"2428_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejca.2019.11.015","volume":"126","author":"C Garbe","year":"2020","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2019. Eur J Cancer. 2020;126:159\u201377.","journal-title":"Eur J Cancer"},{"key":"2428_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(15)00482-9","volume":"17","author":"AJ Hayes","year":"2016","unstructured":"Hayes AJ, Maynard L, Coombes G, Newton-Bishop J, Timmons M, Cook M, et al. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. Lancet Oncol. 2016;17:184\u201392.","journal-title":"Lancet Oncol"},{"key":"2428_CR37","first-page":"397","volume":"43","author":"IE Secinti","year":"2021","unstructured":"Secinti IE, Gursoy D, Erturk T, Dede I, Ozgur T, Dogan E. Should we report Breslow density, a new concept in cutaneous melanoma? Malays J Pathol. 2021;43:397\u2013404.","journal-title":"Malays J Pathol"},{"key":"2428_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/bjd.20421","volume":"185","author":"S Guhan","year":"2021","unstructured":"Guhan S, Klebanov N, Tsao H. Melanoma genomics: a state-of-the-art review of practical clinical applications. Br J Dermatol. 2021;185:272\u201381.","journal-title":"Br J Dermatol"},{"key":"2428_CR39","doi-asserted-by":"crossref","unstructured":"Peach H, Board R, Cook M, Corrie P, Ellis S, Geh J, et al. Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: a UK consensus statement. J Plast Reconstr Aesthet Surg. 2020;73:36\u201342.","DOI":"10.1016\/j.bjps.2019.06.020"},{"key":"2428_CR40","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.3390\/nu13124292","volume":"13","author":"A Martin-Gorgojo","year":"2021","unstructured":"Martin-Gorgojo A, Gilaberte Y, Nagore E. Vitamin D and skin cancer: an epidemiological, patient-centered update and review. Nutrients. 2021;13:4292.","journal-title":"Nutrients"},{"key":"2428_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3538-4","volume":"17","author":"J De Smedt","year":"2017","unstructured":"De Smedt J, Van Kelst S, Boecxstaens V, Stas M, Bogaerts K, Vanderschueren D, et al. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial. BMC Cancer. 2017;17:562.","journal-title":"BMC Cancer"},{"key":"2428_CR42","doi-asserted-by":"crossref","unstructured":"Cunha N, Campos S, Serrao V. Vitamin D levels in a cohort of Portuguese melanoma patients relate to time of follow-up from diagnosis, sun-exposure behaviour, and use of photoprotection. Eur J Dermatol. 2018;28:93\u201394.","DOI":"10.1684\/ejd.2017.3161"},{"key":"2428_CR43","doi-asserted-by":"publisher","first-page":"9823","DOI":"10.18632\/oncotarget.14193","volume":"8","author":"C Skobowiat","year":"2017","unstructured":"Skobowiat C, Oak ASW, Kim T-K, Yang CH, Pfeffer LM, Tuckey RC, et al. Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models. Oncotarget. 2017;8:9823\u201334.","journal-title":"Oncotarget"},{"key":"2428_CR44","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1200\/JCO.2011.34.5967","volume":"29","author":"JY Tang","year":"2011","unstructured":"Tang JY, Fu T, Leblanc E, Manson JE, Feldman D, Linos E, et al. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women\u2019s health initiative randomized controlled trial. J Clin Oncol. 2011;29:3078\u201384.","journal-title":"J Clin Oncol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02428-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02428-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02428-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T17:49:43Z","timestamp":1701971383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02428-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02428-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}